ArticleBMC infectious diseases2025
Machine learning to examine adequate awareness and positive perception of HIV pre-exposure prophylaxis among women in sub-Saharan Africa: evidence from 2021-2024 surveys.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the proven efficacy of HIV pre-exposure prophylaxis (PrEP), adequate awareness and positive perception among women in sub-Saharan Africa (SSA) remain poorly understood, limiting uptake. Existing studies are largely country-specific, focus on limited socio-demographic factors, and rarely leverage advanced analytical methods to identify key determinants. This study addresses these gaps by applying machine learning to population-based surveys across multiple SSA countries.
methodsWe analyzed nationally representative surveys from eight SSA countries conducted between 2021 and 2024, including 123,132 HIV negative women aged 15–49 years. Primary outcomes were adequate awareness and positive perception of PrEP. Predictor variables included socio-demographic characteristics, behavioral factors, healthcare utilization, and contextual features. Data preprocessing included multiple imputation, one-hot encoding, and min–max scaling. Recursive feature elimination and correlation analysis guided feature selection. Five machine learning models—KNN, XGBoost, CatBoost, LightGBM, and Gradient Boosting—were trained and evaluated using accuracy, precision, recall, F1-score, and ROC AUC. SHAP values provided interpretable insights.
resultsOnly 14.9% of women demonstrated adequate awareness and positive perception of PrEP, with marked variation across countries (5.6% in Tanzania to 73.6% in Lesotho). Younger age (15–24 years), lower education, limited media exposure, and minimal healthcare engagement were strongly associated with inadequate awareness. CatBoost outperformed other models (accuracy 0.91, F1-score 0.88), followed by XGBoost (accuracy 0.89, F1-score 0.86). SHAP analysis confirmed age, education, media exposure, healthcare visits, and marital status as the most influential predictors.
conclusionAdequate awareness and positive perception of PrEP among women in SSA remains inadequate and unevenly distributed, highlighting urgent gaps in education and outreach. Machine learning effectively identifies key drivers, enabling targeted interventions to improve PrEP uptake across diverse socio-demographic contexts. These findings can inform country-specific PrEP awareness campaigns and policy strategies to enhance HIV prevention efforts. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.